Drug · DIN 01916971
TUSSIONEX
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since January 29, 2020; first marketed December 31, 1957.
- Drug Identification Number (DIN)
- 01916971
- Company (DIN owner)
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Schedule
- Narcotics (CDSA I)
- Dosage form
- Suspension
- Route
- Oral
- Therapeutic class (ATC)
- Combinations R05DA20
- Class
- Human
- Record last updated
- June 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HYDROCODONE | 5 MG | 5 ML |
| PHENYLTOLOXAMINE | 10 MG | 5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 1, 2019: NOC 22493Supplement to a New Drug Submission (SNDS) · Llabelling update in response to an advisement letter issued by health canada
- March 29, 2006: NOC 7846New Drug Submission (NDS) · Manufacturer name change
- November 10, 2000: NOC 1203New Drug Submission (NDS)
Other DINs named TUSSIONEX
- DIN 01916963 · Cancelled Post Market